Full Name
Zdraveska, Marija
Vernacular Name
Zdraveska M.
 
Variants
Zdraveska M
M. Zdraveska
Marija Zdraveska
Lazarevska Marija
Lazarevska M
Здравеска Марија
Здравеска М
Лазаревска Марија
Лазаревска М
Marija Zdravevska
 
Main Affiliation
 
Loading... 2 0 5 0 false
Loading... 3 0 5 0 false

Refined By:
Type:  Article
Subject:  Venous thromboembolism

Results 1-11 of 11 (Search time: 0.237 seconds).

PreviewTitleAuthor(s)Issue DateType
1The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site.Mahé I; Chidiac J; Bertoletti L; Font C; Trujillo-Santos J; Peris M; Pérez Ductor C; Nieto S; Grandone E; Monreal M; RIETE investigators; Bosevski M ; Zdraveska M 2016Article
2Fondaparinux in the initial and long-term treatment of venous thromboembolismPesavento R; Amitrano M; Trujillo-Santos J; Di Micco P; Mangiacapra S; López-Jiménez L; Piovella C; Prandoni P; Monreal M; RIETE Investigators.; Bosevski M ; Zdraveska M 2015Article
3Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registryAlatri A; Mazzolai L; Font C; Tafur A; Valle R; Marchena PJ; Ballaz A; Tiraferri E; Font L; Monreal M; Riete Investigators; Bosevski M ; Zdraveska M 2017Article
4Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal useÁngeles Blanco-Molina,; Javier Trujillo-Santos,; Raffaele Pesavento,; Vladimir Rosa,; Conxita Falgá,; Carles Tolosa,; Lucia Mazzolai,; Ángel Sampériz,; Rita Duce,; Manuel Monreal; RIETE investigators; Bosevski M ; Zdraveska M 2017Article
5Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M; Registro Informatizado de Enfermedad TromboEmbólica Investigators; Bosevski M ; Zdraveska M 2017Article
6A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism,Gabrielle Sarlon-Bartoli,; Juan Criado,; Saskia Middeldorp,; José Antonio Nieto,; María del Carmen Díaz-Pedroche,; Farès Moustafa,; Nuria Ruiz-Giménez,; Benjamin Brenner,; Manuel Monreal,; Pierpaolo DI Micco,; the RIETE Group; Bosevski, Marijan ; Zdraveska, Marija ; Eftimova A2023Article
7Uterine bleeding during anticoagulation in women with venous thromboembolism.Moustafa F,; Fernández S,; Fernández-Capitán C,; Nieto JA,; Pedrajas JM,; Visoná A,; Valero B,; Marchena PJ,; Braester A,; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2017Article
8Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism.Mellado M,; Trujillo-Santos J,; Bikdeli B,; Jiménez D,; Núñez MJ,; Ellis M,; Marchena PJ, .; Vela JR,; Clara A,; Moustafa F,; Monreal M;; RIETE Investigators; Bosevski M ; Zdraveska M 2019Article
9Venous thromboembolism in centenarians: Findings from the RIETE registryLacruz B; Tiberio G; Núñez MJ; López-Jiménez L; Riera-Mestre A; Tiraferri E; Verhamme P; Mazzolai L; González J; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2016Article
10Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registryPortillo J; de la Rocha VI; Font L; Braester A; Madridano O; Peromingo JA; Apollonio A; Pagán B; Bascuñana J; Monreal M; RIETE Investigations; Bosevski M ; Zdraveska M 2015Article
11Venous thromboembolism in radiation therapy cancer patients: Findings from the RIETE registry,.Jean-Baptiste Guy,; Laurent Bertoletti,; Nicolas Magné,; Chloé Rancoule,; Ihloé Rancoule,; Isabelle Mahé,; Carme Font, ,; Oscar Sanz,; José Manuel Martín-Antorán,; Federica Pace,; Jerónimo Ramón Vela,; Manuel Monreal and the RIETE Investigators; Bosevski M ; Zdraveska M 2017Article